Delivery Order SPE2DB20D2001-SPE2DB25FPMHG

Award Date 3/26/25
Potential Completion Date 4/16/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,385.52, is for a Delivery Order to provide the drug ORGOVYX 120 MG TABLET. The contract has an ultimate completion date of April 16, 2025 and is a Firm Fixed Price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,385.52, is for the delivery of ORGOVYX 120 MG TABLET in quantities of 30s. The contract has an ultimate completion date of February 18, 2025 and is a Firm Fixed Price Delivery Order. This award appears to be part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,385.52, is for the delivery of ORGOVYX 120 MG TABLET to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of May 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,385.52, is for the provision of ORGOVYX 120 MG TABLET pharmaceutical products. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award, valued at $1,375.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORGOVYX 120 MG TABLET, a medical product, to support DLA's medical supply and pharmaceutical needs. The contract is a Firm Fixed Price Delivery Order with a completion date of January 29, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,771.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the medication ORGOVYX 120 MG TABLET, with an ultimate completion date of May 5, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order is for the pharmaceutical product ORGOVYX 120 MG TABLET UU 30S. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.85 firm fixed-price delivery order contract is for the supply of ORGOVYX 120 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,375.85 with a Firm Fixed Price pricing type. The ultimate completion date is December 13, 2024. The contract covers the procurement of ORGOVYX 120 MG TABLET, a pharmaceutical product, to support military healthcare programs. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,313.12, is for the delivery of the prescription drug ORGOVYX 120 MG TABLET in a 30-count supply. The contract is a Firm Fixed Price Delivery Order with a completion date of May 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB25FPMHG
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,385.52 and is a Firm Fixed Price Delivery Order for the pharmaceutical product ORGOVYX 120 MG TABLET. The contract has an ultimate completion date of April 16, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/29/25, 1:18 AM